Dr. Francis Dube on the advancement of mask technologies and ZEN’s graphene based virucidal ink with 99% efficacy

InvestorIntel’s Tracy Weslosky speaks with Dr. Francis Dube, CEO and Director of ZEN Graphene Solutions Ltd. (TSXV: ZEN), about ZEN’s novel graphene based virucidal ink. “We have come up with a coating that can be applied to masks and filter membranes to deactivate the COVID-19 virus,” Dr. Dube told InvestorIntel. “It has been proven at plus 99% efficacy through Western University’s ImPaKT facility which is a Biosafety Level 3 lab.”

In an InvestorIntel interview that can also be viewed on our InvestorIntel YouTube channel, Dr. Dube went on to say, while the current mask technologies are only meant to filter out particles, masks sprayed with ZEN’s graphene-based virucidal ink remains 99% effective in killing COVID-19 virus even after 35 days.

To watch the full interview, click here

To learn more about ZEN Graphene Solutions Ltd., click here

Disclaimer: ZEN Graphene Solutions Ltd. is an advertorial member of InvestorIntel Corp.

Disclaimer: Video interviews and other video content published by InvestorNews.com are produced as part of paid media services. The issuer or company featured in this video interview has compensated InvestorNews for the creation and publication of such content. The views expressed in these interviews are those of the interviewees or guests and do not necessarily reflect the opinions or positions of InvestorNews, its writers, or its affiliates. All InvestorNews advertisers are publicly disclosed and listed on the InvestorNews Members page of InvestorNews.com. For full details, please refer to our complete disclaimer at investornews.com/disclaimer or e-mail [email protected] for further information.

Leave a Reply

Your email address will not be published. Required fields are marked *